← Back to Search

Diabetes Discharge Toolkit for Diabetes

N/A

Recruiting

Led By Amisha Wallia, MD

Research Sponsored by Northwestern University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

English speaking patients

18 years of age and older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 14, 30 and 90 days

Awards & highlights

Study Summary

This trial will test if a new toolkit can help patients transition safely from hospital to home with insulin.

Who is the study for?

This trial is for adults over 18 who have recently been prescribed insulin at hospital discharge, expected to live more than 90 days, and speak English. It's not suitable for those without a new insulin prescription, without a diabetes diagnosis, non-English speakers, or anyone unable to consent.Check my eligibility

What is being tested?

The study is testing the 'DM Discharge Toolkit' designed to help patients manage their new insulin treatment after leaving the hospital. Participants are randomly chosen to receive this toolkit to see if it improves their care post-discharge.See study design

What are the potential side effects?

Since this trial involves educational material rather than medication, there are no direct medical side effects. However, participants may experience stress or confusion if the information is overwhelming or unclear.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I speak English.

Select...

I am 18 years old or older.

Select...

I need to start insulin when I leave the hospital.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 14, 30 and 90 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~14, 30 and 90 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 14, 30 and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Mean glucose levels

Secondary outcome measures

Diabetes Distress Scale

Diabetes Symptoms Questionnaire

Glycemic variability

+12 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: DM Discharge ToolkitExperimental Treatment1 Intervention

Up to 60 participants will be recruited for the intervention group. Participants will receive the current standard of care DM education for insulin at Northwestern Memorial Hospital and the adjunctive education with the DM Discharge Toolkit.

Group II: Current Standard of Care Discharge DM TrainingActive Control1 Intervention

Up to 60 participants will be recruited for the control group. Participants will receive the current standard of care DM education for insulin use during current discharge care processes at Northwestern Memorial Hospital.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor

1,589 Previous Clinical Trials

917,006 Total Patients Enrolled

Amisha Wallia, MDPrincipal InvestigatorNorthwestern University

Media Library

DM Discharge Toolkit Clinical Trial Eligibility Overview. Trial Name: NCT05663931 — N/A

Type 1 Diabetes Research Study Groups: DM Discharge Toolkit, Current Standard of Care Discharge DM Training

Type 1 Diabetes Clinical Trial 2023: DM Discharge Toolkit Highlights & Side Effects. Trial Name: NCT05663931 — N/A

DM Discharge Toolkit 2023 Treatment Timeline for Medical Study. Trial Name: NCT05663931 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who qualifies to engage in this clinical research?

"Prospective participants of this medical trial must have type 2 diabetes mellitus and be between 18-90 years old. The study has a target enrolment of 120 patients in total."

Answered by AI

Does this research permit patients aged sixty-five and above to participate?

"This medical research program has an age range of 18 to 90 for potential participants. Currently, there are 228 trials available for those below 18 and 1140 studies open to people over 65 years old."

Answered by AI

Are patients being recruited for this research trial currently?

"Confirmed, the data hosted on clinicaltrials.gov shows that this trial is not actively looking for candidates. The posting date was December 21st 2022 and it saw its last update dated 15th of December 2022. Despite this, there are still 1,511 clinical trials which require participants at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Diabetes Toolkit at Discharge

Amisha Wallia 2023. "Diabetes Toolkit at Discharge". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05663931.